RSS Feed
- Employers: Entry-Level Applicants Are Just About Useless
- Tesla Pops on GM Rumor (Update 1)
- Walmart vs. Costco: How Do They Really Compare?
- Why Apple Sucks as an Investment, but Amazon Doesn't
- Amarin: FDA Panel Date, Misplaced Hype For Fixed-Dose Combo
Article
Amgen Drug Delays Ovarian Cancer Re-Growth, Survival Benefit Unclear
Amgen may have a tough time getting FDA approval for trebananib without a survival benefit.
09:57AM 06/12/13
Article
Vertex's Roadmap to $10 Billion in Cystic Fibrosis Drug Sales
Combinations of various Vertex drugs could benefit 90% of cystic fibrosis patients.
09:00AM 06/11/13
Article
Five Best-Performing Biotech Stocks of 2013 (Some May Surprise You)
In a bubbly year for the biotech sector, these five stocks stand out over the rest.
07:00AM 06/11/13
Article
Ampio Blames Shorts But Won't Answer Legitimate Questions About Its Drugs
Ampio attacks critics instead of answering legitimate questions.
12:21PM 06/10/13
Article
Biotech Stock Mailbag: 2013 Clinical Trials Calendar
Biotech columnist Adam Feuerstein answers readers' questions about healthcare companies.
07:00AM 06/07/13
Article
As If Amarin Needs Another Worry, Here Comes A Vascepa FDA Panel
Amarin's president says company is preparing for FDA advisory panel seeking expansion of fish-oil pill's use.
11:10AM 06/06/13
Article
Aveo Fires 140 Workers As Punishment For CEO's Incompetence
The failure of a kidney cancer drug won't stop Aveo executives from cashing future paychecks.
11:06AM 06/05/13
Article
Clovis Doubles on Buzz Over Lung Cancer Drug
Surprisingly strong results for a lung cancer drug have helped Clovis double in value today.
01:31PM 06/03/13
Article
Synta's Lung Cancer Drug Struggles to Remain Relevant
A narrowing of the survival benefit plus competition from anti-PD1s makes Synta's ganetespib success a long shot.
09:18AM 06/03/13
Article
Bristol And Merck's Cancer Drugs Won ASCO. Five Slides Explain Why.
The anti-PD-1s are shrinking tumors like no drugs have done before and investors are really excited.
09:09AM 06/03/13